CD5 expression in diffuse large B-cell lymphoma
Main Authors: | Sanaa Bouchnafati, Hajar Masrour, Mounia Bouzayd, Widad Rhandour, Oudrhiri Anas, Laila Abarkan, Nabil Al Saddiq, Latifa Lerhrib, Rim Hanini, Yassine Chekkori, Falah Eddine Tohir, Maha Ouazzani, Naoual Oubelkacem, Noufissa Alami Drideb, Zineb Khammar, Rhizlane Berrady |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Journal of Taibah University Medical Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1658361223001968 |
Similar Items
-
Refractory diffuse large B-cell Lymphoma
by: Hajar Masrour, et al.
Published: (2023-01-01) -
Adverse effects of Imatinib in patients with chronic myeloid leukemia
by: Hajar Masrour, et al.
Published: (2023-01-01) -
BCL2 overexpression in diffuse large B-cell Lymphoma
by: Hajar Masrour, et al.
Published: (2023-01-01) -
The Bulky mass in diffuse large B Cell Lymphoma: Prognostic impact? A treatment guiding factor?
by: Masrour, et al.
Published: (2023-01-01) -
Case report: Long-term voluntary Tyrosine Kinase Inhibitor (TKI) discontinuation in chronic myeloid leukemia (CML): Molecular evidence of an immune surveillance
by: Jusuf Imeri, et al.
Published: (2023-03-01)